Voyager Reports First Quarter 2026 Financial Results, Reports 1Q Record Backlog, Increases 2026 Revenue Guidance
Based on accelerating and record backlog of
Business and Financial Performance Highlights
-
Strong start to 2026 with a record Backlog of
$275.3 million , an increase of 54% year over year -
1Q Bookings of
$45.2 million , Book-to-Bill ratio 1.3 -
Strong momentum continued into early 2Q, evidenced by multiple
Golden Dome program awards and recentNASA award ofPrivate Astronaut Mission to ISS -
Delivered 1Q net sales of
$35.2 million -
Robust balance sheet, including
$429.4 million in cash and cash equivalents, and total liquidity of$641.4 million , including$212 million available capacity under our revolver -
Raising 2026 Revenue guidance range to
$230 million to$255 million , a significant acceleration of 39-53% over last year, underscoring execution of our growth strategy
"We achieved a new record backlog with strong bookings across all of our core technologies," said
"Our Defense and Space Technologies segment remains a powerful growth engine, fueled by strong customer engagement and new business wins across several key missile defense programs, in addition to continued execution on the Next Generation Interceptor. Voyager is deeply aligned with the highest-priority national security objectives, driving a new record backlog that grew to
"Our strong liquidity position of
"With a record backlog, sustained budget momentum, mission urgency, and a growing domestic manufacturing capability, we are extremely well positioned to significantly accelerate our revenue growth relative to last year."
Business and Financial Performance Results
Voyager began 2026 with strong operational momentum, delivering first-quarter bookings of
Net sales of
Innovation is a foundational pillar of our long-term strategy and a key differentiator across the defense, national security and space sectors. For the three month ended
Profitability reflects continued investment in long-term growth initiatives, including the ramp-up of Starlab program activities and increased spending on innovation. For the quarter, we reported a net loss of
Voyager maintains a strong financial position, ending the quarter with
Defense and Space Technologies Segment Highlights
Voyager’s Defense and Space Technologies segment delivers a diversified portfolio of mission-critical capabilities across strategic systems, advanced electronics, spectrum dominance, mission management, and space infrastructure. The segment supports key national security and space programs with strengths in propulsion and energetics, sensing and ISR, communications, AI/ML-enabled data exploitation, and guidance, navigation, and control.
Orders for the three months ended
Net sales for the three months ended
Starlab Space Stations Segment Highlights
Our Starlab Space Stations segment is a Voyager-led, majority-owned joint venture focused on developing the commercial replacement for the
Business Outlook for the Full Year 2026
For the full year 2026, we increased our guidance range to
The foregoing estimates are forward-looking and reflect management’s view of current and future market conditions, subject to certain risks and uncertainties, including certain assumptions with respect to our ability to efficiently and on a timely basis integrate acquisitions, obtain and retain contracts, changes in the timing and/or amount of government spending, react to changes in the demand for our products, activities of competitors, changes in the regulatory environment, and general economic and business conditions in
Conference Call and Live Webcast
A live webcast of the call will be made available on the Events & Presentations section of Voyager’s Investor Relations website at investors.voyagertechnologies.com. The earnings release and presentation will be posted to the Investor Relations website prior to the call.
A replay of the call will be available approximately one hour after the call through the archived webcast on the Events & Presentations section of Voyager’s Investor Relations website.
Audio Replay
An audio replay of the event will be archived on the Investor Relations section of the Company's website at https://investors.voyagertechnologies.com.
About
Non-GAAP Financial Measures
Non-GAAP financial measures are not calculated or presented in accordance with GAAP and other companies in our industry may calculate them differently than we do. As a result, non-GAAP financial measures have limitations as analytical and comparative tools and you should not consider them in isolation, or as a substitute, for analysis of our results as reported under GAAP. In addition, in evaluating Adjusted EBITDA, adjusted earnings per share and free cash flow, you should be aware that in the future we may incur expenses similar to those eliminated in this presentation. Our presentation of Adjusted EBITDA, adjusted loss per share and free cash flow should not be construed as an inference that our future results will be unaffected by unusual items. Management compensates for these limitations by primarily relying on our GAAP results in addition to using Adjusted EBITDA, adjusted earnings per share and free cash flow supplementally.
Adjusted EBITDA
We consider Adjusted EBITDA to be a useful, supplemental, measure of our operating performance. We use Adjusted EBITDA to supplement GAAP measures in evaluating the performance of our business and the effectiveness of our strategies, to make budgeting decisions, make certain compensation decisions, and to compare our performance against that of our peer companies, many of which present similar non-GAAP financial measures.
In addition, we believe Adjusted EBITDA provides a useful measure for period-to-period comparisons of our business, as they remove the impact of our capital structure and other items not indicative of our core operating performance from operating results.
We define EBITDA as net loss attributable to
Free Cash Flow
We consider free cash flow to be a useful, supplemental measure of our ability to generate cash on a normalized basis. We use free cash flow to supplement GAAP measures in evaluating our flexibility to allocate capital and pursue opportunities that may enhance shareholder value and the effectiveness of our strategies, to make budgeting decisions and to compare our performance against that of our peer companies, many of which present similar non-GAAP financial measures.
We believe that while expenditures and dispositions of property, plant and equipment will fluctuate on a period-to-period basis, we seek to ensure that we have adequate capital on hand to maintain ongoing operations and enable growth of the business. Additionally, free cash flow is of limited usefulness in that it does not represent residual cash flows available for discretionary expenditures due to the fact the measures do not deduct the payments required for debt service and other contractual obligations or payments.
We define free cash flow as the sum of our cash (used in) provided by operating activities less our net capital expenditures. The net capital expenditures of the Company are defined as the gross capital expenditures for the purchase of property and equipment less the grant funding we received in order to make such purchases. Based on the nature of government grants for purposes of funding capital expenditures on our Starlab program, these grants are pass through for purposes of making capital expenditures as they are directly used to source funding on capital expenditures. Our calculation of free cash flow may not be comparable to the calculation of similarly titled measures reported by other companies.
Adjusted Earnings Per Share
We consider adjusted earnings per share to be a useful, supplemental measure of our operations on a per share basis adjusting for items that are considered either non-operational or significant infrequent expenses or that are sources of income that are not recurring to the business on a frequent basis. We define adjusted earnings per share as the net income/loss attributable to common stockholders adjusted for stock-based compensation, business acquisition costs, restructuring, deferred income tax expense, and other items mainly related to financing expenses and other individually immaterial items divided by our diluted basis number of weighted average shares outstanding during the period. Since the adjustments made for presentational purposes do not impact the tax basis of the Company, the adjustments have been presented on a tax free basis.
Innovation Spend
We are focused on delivering innovative solutions to the defense, national security and space end markets, and research and development is at the core of our business. We believe innovation spend and innovation spend excluding Starlab provide our management and investors useful measures of our aggregate spend on research and development type activities in support of our customers’ needs and our future growth.
However, innovation spend is an operating metric, not a financial measure calculated or presented in accordance with GAAP, and companies in our industry may calculate innovation spend or similar operating metrics differently than we do. We define innovation spend as research and development costs associated with
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. We intend all forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements in this presentation that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding Voyager’s financial outlook, anticipated financial and operational performance and liquidity, including without limitation, long-term cash generation, and other projections. The words “expect,” “expectation,” “believe,” “anticipate,” “may,” “could,” “intend,” “belief,” “plan,” “estimate,” “target,” “predict,” “likely,” “seek,” “project,” “model,” “ongoing,” “will,” “should,” “forecast,” “outlook” or similar terminology are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These forward-looking statements are based on and reflect our current expectations, estimates, assumptions and/or projections, our perception of historical trends and current conditions, as well as other factors that we believe are appropriate and reasonable under the circumstances. Forward-looking statements are neither promises nor guarantees of future events, circumstances or performance and are inherently subject to known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements to differ materially from those indicated by those statements including, but not limited to: our ability to generate, sustain and manage our growth given our limited operating history in an evolving industry; factors out of our control that affect our success and revenue growth; our ability to generate a sustainable order rate for our products and services and develop new technologies to meet customer needs; our compliance with development contracts with third-parties and losses from fixed price contracts; our history of losses and ability to achieve profitability; risks related to Starlab; the unpredictable environment of space; our customer concentration and risks with contracting with the
The forward-looking statements included in this announcement are only made as of the date of this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable law.
Website Disclosure
Investors and others should note that we announce material financial and operational information to our investors using press releases,
|
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited, in thousands, except share and per share amounts) |
|||||||
|
|
|
|
|
||||
|
ASSETS |
|||||||
|
Current assets: |
|
|
|
||||
|
Cash and cash equivalents |
$ |
429,361 |
|
|
$ |
491,329 |
|
|
Accounts receivable, net |
|
12,163 |
|
|
|
29,819 |
|
|
Contract assets |
|
35,796 |
|
|
|
29,786 |
|
|
Inventories |
|
5,720 |
|
|
|
3,825 |
|
|
Prepaid expenses and other current assets |
|
25,664 |
|
|
|
26,541 |
|
|
TOTAL CURRENT ASSETS |
|
508,704 |
|
|
|
581,300 |
|
|
Property and equipment, net |
|
191,433 |
|
|
|
164,286 |
|
|
Operating lease right-of-use assets |
|
41,900 |
|
|
|
18,164 |
|
|
Intangible assets, net |
|
94,749 |
|
|
|
98,982 |
|
|
|
|
157,674 |
|
|
|
157,674 |
|
|
Other assets |
|
29,259 |
|
|
|
30,048 |
|
|
TOTAL ASSETS |
$ |
1,023,719 |
|
|
$ |
1,050,454 |
|
|
|
|
|
|
||||
|
LIABILITIES AND EQUITY |
|
|
|
||||
|
Current liabilities: |
|
|
|
||||
|
Accounts payable |
$ |
19,851 |
|
|
$ |
27,386 |
|
|
Contract liabilities |
|
16,919 |
|
|
|
24,338 |
|
|
Operating lease liabilities |
|
6,757 |
|
|
|
5,831 |
|
|
Accrued expenses and other current liabilities |
|
67,726 |
|
|
|
75,472 |
|
|
TOTAL CURRENT LIABILITIES |
|
111,253 |
|
|
|
133,027 |
|
|
Operating lease liabilities, non-current |
|
36,296 |
|
|
|
13,336 |
|
|
Contract liabilities, non-current |
|
7,903 |
|
|
|
7,899 |
|
|
Convertible notes, net |
|
448,268 |
|
|
|
447,634 |
|
|
Deferred tax liabilities |
|
12,021 |
|
|
|
8,858 |
|
|
Other long-term liabilities |
|
3,506 |
|
|
|
10,167 |
|
|
TOTAL LIABILITIES |
$ |
619,247 |
|
|
$ |
620,921 |
|
|
Class A common stock: |
|
5 |
|
|
|
5 |
|
|
Class B common stock: |
|
1 |
|
|
|
1 |
|
|
Additional paid-in capital |
|
823,076 |
|
|
|
797,438 |
|
|
|
|
(35,880 |
) |
|
|
(27,702 |
) |
|
Accumulated other comprehensive loss |
|
(64 |
) |
|
|
(95 |
) |
|
Accumulated deficit |
|
(429,910 |
) |
|
|
(385,927 |
) |
|
|
|
357,228 |
|
|
|
383,720 |
|
|
Noncontrolling interests |
|
47,244 |
|
|
|
45,813 |
|
|
TOTAL EQUITY |
|
404,472 |
|
|
|
429,533 |
|
|
TOTAL LIABILITIES AND EQUITY |
$ |
1,023,719 |
|
|
$ |
1,050,454 |
|
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited, in thousands, except share and per share amounts) |
|||||||
|
|
Three Months Ended |
||||||
|
|
|
|
|
||||
|
Net sales |
$ |
35,246 |
|
|
$ |
34,507 |
|
|
Cost of sales |
|
36,792 |
|
|
|
28,922 |
|
|
Gross (loss) profit |
|
(1,546 |
) |
|
|
5,585 |
|
|
Operating expenses: |
|
|
|
||||
|
Selling, general, and administrative |
|
31,357 |
|
|
|
26,286 |
|
|
Research and development |
|
7,511 |
|
|
|
4,040 |
|
|
Amortization of acquired intangibles |
|
4,233 |
|
|
|
1,548 |
|
|
Loss from operations |
$ |
(44,647 |
) |
|
$ |
(26,289 |
) |
|
Other income (expense): |
|
|
|
||||
|
Finance and interest expense, net |
|
(2,114 |
) |
|
|
(2,729 |
) |
|
Other income, net |
|
4,043 |
|
|
|
1,137 |
|
|
Loss before income taxes |
|
(42,718 |
) |
|
|
(27,881 |
) |
|
Income tax expense |
|
3,226 |
|
|
|
48 |
|
|
Net loss |
|
(45,944 |
) |
|
|
(27,929 |
) |
|
Net loss attributable to noncontrolling interests |
|
(1,961 |
) |
|
|
(991 |
) |
|
Net loss attributable to |
|
(43,983 |
) |
|
|
(26,938 |
) |
|
Less: dividends accrued on preferred stock |
|
— |
|
|
|
6,001 |
|
|
Net loss available to common shareholders |
|
(43,983 |
) |
|
|
(32,939 |
) |
|
|
|
|
|
||||
|
Net loss per common share: |
|
|
|
||||
|
Basic |
$ |
(0.75 |
) |
|
$ |
(2.30 |
) |
|
Diluted |
$ |
(0.75 |
) |
|
$ |
(2.30 |
) |
|
Weighted-average shares outstanding: |
|
|
|
||||
|
Basic |
|
58,339,505 |
|
|
|
14,339,521 |
|
|
Diluted |
|
58,339,505 |
|
|
|
14,339,521 |
|
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited, in thousands) |
|||||||
|
|
Three Months Ended |
||||||
|
|
|
|
|
||||
|
Cash Flows from Operating Activities: |
|
|
|
||||
|
Net loss |
$ |
(45,944 |
) |
|
$ |
(27,929 |
) |
|
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
||||
|
Depreciation and amortization |
|
6,033 |
|
|
|
2,602 |
|
|
Stock-based compensation |
|
4,112 |
|
|
|
1,723 |
|
|
Amortization of operating lease right-of-use assets |
|
1,205 |
|
|
|
670 |
|
|
Amortization of debt issuance costs and other non-cash interest expense |
|
994 |
|
|
|
1,291 |
|
|
Deferred taxes |
|
3,163 |
|
|
|
65 |
|
|
Non-cash services acquired |
|
4,375 |
|
|
|
10,115 |
|
|
Other |
|
(77 |
) |
|
|
(73 |
) |
|
Change in operating assets and liabilities, net of acquisitions: |
|
|
|
||||
|
Accounts receivable |
|
14,054 |
|
|
|
7,528 |
|
|
Prepaid expenses and other current assets |
|
(2,231 |
) |
|
|
(3,165 |
) |
|
Contract assets |
|
(6,010 |
) |
|
|
(1,227 |
) |
|
Inventories |
|
(1,895 |
) |
|
|
284 |
|
|
Other assets |
|
596 |
|
|
|
(485 |
) |
|
Accounts payable |
|
(4,280 |
) |
|
|
(10 |
) |
|
Contract liabilities |
|
(7,415 |
) |
|
|
(5,258 |
) |
|
Accrued expenses |
|
(5,319 |
) |
|
|
252 |
|
|
Operating lease liabilities |
|
(1,055 |
) |
|
|
(756 |
) |
|
Other liabilities |
|
(18 |
) |
|
|
19 |
|
|
Net cash used in operating activities |
$ |
(39,712 |
) |
|
$ |
(14,354 |
) |
|
|
|
|
|
||||
|
Cash Flows from Investing Activities: |
|
|
|
||||
|
Purchases of property and equipment |
|
(51,116 |
) |
|
|
(26,970 |
) |
|
Grant funding for property and equipment |
|
24,034 |
|
|
|
18,000 |
|
|
Acquisition working capital settlement |
|
(5,837 |
) |
|
|
— |
|
|
Net cash used in investing activities |
$ |
(32,919 |
) |
|
$ |
(8,970 |
) |
|
|
|
|
|
||||
|
Cash Flows from Financing Activities: |
|
|
|
||||
|
Proceeds from the exercise of stock options |
|
3,643 |
|
|
|
114 |
|
|
Proceeds from the issuance of Common stock, net |
|
— |
|
|
|
43,161 |
|
|
Proceeds from the issuance of Class C preferred stock, net |
|
— |
|
|
|
99,449 |
|
|
Sale of noncontrolling interest |
|
7,039 |
|
|
|
— |
|
|
2024 convertible note |
|
— |
|
|
|
130 |
|
|
Net cash provided by financing activities |
$ |
10,682 |
|
|
$ |
142,854 |
|
|
|
|
|
|
||||
|
Effect of foreign exchange on cash and cash equivalents |
$ |
(19 |
) |
|
$ |
28 |
|
|
Net (decrease) increase in cash and cash equivalents |
|
(61,968 |
) |
|
|
119,558 |
|
|
Cash and cash equivalent at the beginning of the period |
|
491,329 |
|
|
|
55,930 |
|
|
Cash and cash equivalents at the end of the period |
$ |
429,361 |
|
|
$ |
175,488 |
|
|
TABLE 1 - (Unaudited, in thousands) |
|||||||||||||
|
|
Three Months Ended |
|
Change |
||||||||||
|
|
|
|
|
|
Year over Year |
|
% |
||||||
|
|
|
|
|
|
|
|
|
||||||
|
Defense and Space Technologies |
$ |
36,157 |
|
|
$ |
35,848 |
|
|
$ |
309 |
|
0.9 |
% |
|
Starlab Space Stations |
|
— |
|
|
|
— |
|
|
|
— |
|
— |
|
|
Total |
|
36,157 |
|
|
|
35,848 |
|
|
|
309 |
|
0.9 |
% |
|
Intersegment eliminations |
|
(911 |
) |
|
|
(1,341 |
) |
|
|
430 |
|
(32.1 |
)% |
|
Total |
$ |
35,246 |
|
|
$ |
34,507 |
|
|
$ |
739 |
|
2.1 |
% |
|
TABLE 2 - ADJUSTED EBITDA (Unaudited, in thousands) |
|||||||
|
|
Three Months Ended |
||||||
|
(dollars in thousands) |
|
|
|
||||
|
Net loss attributable to |
$ |
(43,983 |
) |
|
$ |
(26,938 |
) |
|
Finance and interest expense, net |
|
2,114 |
|
|
|
2,729 |
|
|
Depreciation and amortization |
|
6,033 |
|
|
|
2,602 |
|
|
Income tax expense |
|
3,226 |
|
|
|
48 |
|
|
EBITDA |
|
(32,610 |
) |
|
|
(21,559 |
) |
|
Stock-based compensation |
|
4,129 |
|
|
|
1,723 |
|
|
Business acquisition costs(1) |
|
411 |
|
|
|
156 |
|
|
Restructuring(2) |
|
744 |
|
|
|
418 |
|
|
Net loss attributable to noncontrolling interests |
|
(1,961 |
) |
|
|
(991 |
) |
|
Interest income |
|
(3,819 |
) |
|
|
(1,085 |
) |
|
Other(3) |
|
(225 |
) |
|
|
(18 |
) |
|
Adjusted EBITDA |
$ |
(33,331 |
) |
|
$ |
(21,356 |
) |
| ____________ | ||
|
(1) |
Business acquisition costs include legal costs and incremental transaction costs associated with an acquisition. |
|
|
(2) |
Restructuring includes costs for retention and severance payments related to management’s decision to undertake certain actions to realign our cost structure through workforce reductions and the closure of certain facilities, businesses and product lines. |
|
|
(3) |
Other includes capital market and advisory fees related to advisors assisting with transitional activities associated with becoming a public company, changes in fair value of earn out liabilities, and foreign exchange gain/loss that are all individually insignificant for the period. |
|
|
TABLE 3 - FREE CASH FLOW (Unaudited, in thousands) |
|||||||
|
|
Three Months Ended |
||||||
|
(dollars in thousands) |
|
|
|
||||
|
Net cash used in operating activities |
$ |
(39,712 |
) |
|
$ |
(14,354 |
) |
|
Purchases of property and equipment |
|
(51,116 |
) |
|
|
(26,970 |
) |
|
Grant funding for property and equipment |
|
24,034 |
|
|
|
18,000 |
|
|
Free cash flow |
$ |
(66,794 |
) |
|
$ |
(23,324 |
) |
|
TABLE 4 - ADJUSTED EARNINGS PER SHARE (Unaudited, in thousands) |
|||||||
|
|
Three Months Ended |
||||||
|
(dollars in thousands, except per share data) |
|
|
|
||||
|
Net loss attributed to common shareholders |
$ |
(43,983 |
) |
|
$ |
(32,939 |
) |
|
Stock-based compensation |
|
4,129 |
|
|
|
1,723 |
|
|
Business acquisition costs(1) |
|
411 |
|
|
|
156 |
|
|
Restructuring(2) |
|
744 |
|
|
|
418 |
|
|
Deferred income tax expense |
|
3,163 |
|
|
|
(2 |
) |
|
Other(3) |
|
(225 |
) |
|
|
(18 |
) |
|
Adjusted net loss attributable to common shareholders |
|
(35,761 |
) |
|
|
(30,662 |
) |
|
Adjusted net loss per common share |
$ |
(0.61 |
) |
|
$ |
(2.14 |
) |
| ____________ | ||
| (1) |
Business acquisition costs include legal costs and incremental transaction costs associated with an acquisition. |
|
| (2) |
Restructuring includes costs for retention and severance payments related to management’s decision to undertake certain actions to realign our cost structure through workforce reductions and the closure of certain facilities, businesses and product lines. |
|
| (3) |
Other includes capital market and advisory fees related to advisors assisting with transitional activities associated with becoming a public company, changes in fair value of earn out liabilities, and foreign exchange gain/loss that are all individually insignificant for the period. |
|
|
TABLE 5 - INNOVATION SPEND (Unaudited, in thousands) |
|||||||
|
|
Three Months Ended |
||||||
|
(dollars in thousands) |
|
|
|
||||
|
Qualified research and development under section 174 |
$ |
45,040 |
|
|
$ |
33,599 |
|
|
Development program innovation spend(1) |
|
8,318 |
|
|
|
5,513 |
|
|
Innovation spend |
|
53,358 |
|
|
|
39,112 |
|
|
Less: Starlab Space Stations innovation spend |
|
36,571 |
|
|
|
29,378 |
|
|
Innovation spend excluding Starlab Space Stations |
$ |
16,787 |
|
|
$ |
9,734 |
|
|
Innovation spend as a percentage of net sales |
|
151.4 |
% |
|
|
113.3 |
% |
|
Innovation spend excluding Starlab Space Stations as a percentage of net sales |
|
47.6 |
% |
|
|
28.2 |
% |
| ____________ | ||
|
(1) |
Development program innovation spend represents program spend on designated innovation programs within the business that is necessary for fulfillment of performance obligations on revenue generating programs. |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20260504054092/en/
For additional media and information, please follow us:
LinkedIn
X
Investor contact:
investors@voyagertechnologies.com
Media contact:
dana.carroll@voyagertechnologies.com
Source: